Spots Global Cancer Trial Database for liver cancer, adult
Every month we try and update this database with for liver cancer, adult cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma | NCT02191878 | Hepatocellular ... Hepatoma Liver Cancer, A... Liver Cell Carc... | TKM-080301 | 18 Years - | Arbutus Biopharma Corporation | |
| Analgesia by Transversus Abdominis Plane Nerve Block in Patients Undergoing Liver Resection. | NCT02527577 | Liver Cancer, A... | RopivacaIne chl... Placebo | 18 Years - | Centre Hospitalier Universitaire de Saint Etienne | |
| Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients | NCT05171335 | Hepatocellular ... | Lenvatinib Transcatheter A... | 18 Years - | The Methodist Hospital Research Institute | |
| TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma | NCT02704130 | Hepatocellular ... Hepatoma Liver Cancer, A... Liver Cell Carc... Liver Cell Carc... | Transarterial e... Microwave Ablat... | 18 Years - 75 Years | Wake Forest University Health Sciences | |
| Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC | NCT05195294 | Hepatocellular ... Liver Cancer, A... Liver Cell Carc... | LioCyx-M Lenvatinib | 18 Years - 75 Years | Lion TCR Pte. Ltd. | |
| Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma | NCT00669136 | Hepatocellular ... Hepatoma Liver Cancer, A... Liver Cell Carc... Liver Cell Carc... Cancer of Liver Cancer of the L... Cancer, Hepatoc... Hepatic Cancer Hepatic Neoplas... Hepatocellular ... Liver Cancer Neoplasms, Hepa... Neoplasms, Live... | AFP + GM-CSF Pl... | 18 Years - 80 Years | University of Pittsburgh | |
| Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients | NCT05171335 | Hepatocellular ... | Lenvatinib Transcatheter A... | 18 Years - | The Methodist Hospital Research Institute | |
| Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer | NCT02942329 | Gastric Cancer Hepatocellular ... | apatinib SHR-1210 | 18 Years - 70 Years | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | |
| Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma | NCT00669136 | Hepatocellular ... Hepatoma Liver Cancer, A... Liver Cell Carc... Liver Cell Carc... Cancer of Liver Cancer of the L... Cancer, Hepatoc... Hepatic Cancer Hepatic Neoplas... Hepatocellular ... Liver Cancer Neoplasms, Hepa... Neoplasms, Live... | AFP + GM-CSF Pl... | 18 Years - 80 Years | University of Pittsburgh | |
| Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients | NCT05171335 | Hepatocellular ... | Lenvatinib Transcatheter A... | 18 Years - | The Methodist Hospital Research Institute | |
| Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer | NCT02942329 | Gastric Cancer Hepatocellular ... | apatinib SHR-1210 | 18 Years - 70 Years | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | |
| Liver Function Investigation With SPECT | NCT02967848 | Liver Cancer, A... | 99mTc-mebrofeni... Indocyanine Gre... Liver Elasticit... | 18 Years - 100 Years | Royal North Shore Hospital | |
| A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors | NCT04567615 | Hepatocellular ... Hepatoma Liver Cancer, A... Liver Cell Carc... Liver Cell Carc... | Nivolumab Relatlimab | 18 Years - | Bristol-Myers Squibb | |
| A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma | NCT03674073 | Hepatocellular ... Liver Cancer, A... | Neoantigen Vacc... Microwave Ablat... | 18 Years - | Chinese PLA General Hospital | |
| Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7 | NCT04777851 | Carcinoma, Hepa... | Regorafenib in ... Loco-regional t... | 18 Years - | Translational Research in Oncology | |
| Advanced Image Guidance Utilized in Liver Surgery | NCT01666145 | Carcinoma, Hepa... | Advanced Image ... | 18 Years - | Wake Forest University Health Sciences | |
| Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions | NCT02095678 | Hepatocellular ... | liver biopsy free-breathing ... | 18 Years - 100 Years | Case Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
